Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Short-term Investments (2023 - 2026)

GeneDx Holdings has reported Short-term Investments over the past 4 years, most recently at $76.8 million for Q1 2026.

  • Quarterly Short-term Investments rose 29.11% to $76.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $76.8 million through Mar 2026, up 29.11% year-over-year, with the annual reading at $66.3 million for FY2025, 18.42% up from the prior year.
  • Short-term Investments was $76.8 million for Q1 2026 at GeneDx Holdings, up from $66.3 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $76.8 million in Q1 2026 and troughed at $12.1 million in Q1 2023.
  • The 4-year median for Short-term Investments is $57.3 million (2024), against an average of $48.8 million.
  • Year-over-year, Short-term Investments surged 140.77% in 2024 and then grew 0.93% in 2025.
  • A 4-year view of Short-term Investments shows it stood at $30.5 million in 2023, then skyrocketed by 83.72% to $56.0 million in 2024, then rose by 18.42% to $66.3 million in 2025, then grew by 15.8% to $76.8 million in 2026.
  • Per Business Quant, the three most recent readings for WGS's Short-term Investments are $76.8 million (Q1 2026), $66.3 million (Q4 2025), and $59.1 million (Q3 2025).